Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge

Jaeyun Jung1, Chanjoo Yeom2, Yeon-Sook Choi2

  • 1Department of Biomedical Sciences, University of Ulsan School of Medicine, Seoul 138-736, Korea.

Oncotarget
|August 19, 2015
PubMed

Insights

This study introduces a multi-potent miRNA sponge that simultaneously inhibits multiple oncogenic microRNAs (miRNAs). This novel tool effectively targets key miRNAs in cancer cells, offering potential therapeutic applications.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biotechnology

Background:

  • Oncogenic microRNAs (miRNAs) play significant roles in cancer development.
  • Single miRNA inhibition has limitations due to transient effects and compensatory mechanisms.
  • Targeting multiple oncogenic miRNAs simultaneously presents a promising strategy for cancer therapy.

Purpose of the Study:

  • To develop and validate a multi-potent miRNA sponge capable of inhibiting multiple oncogenic miRNAs concurrently.
  • To investigate the efficacy of the miRNA sponge in reducing target miRNA levels and affecting protein expression.
  • To assess the potential of the miRNA sponge in sensitizing cancer cells to drugs and reducing migratory activity.

Main Methods:

  • Design and construction of a multi-potent miRNA sponge with multiple miRNA binding sites (MBS).
  • Utilizing luciferase reporter assays to confirm miRNA inhibition in breast and pancreatic cancer cells.
  • Generation of a stable, inducible cell line for long-term miRNA sponge expression and analysis.
  • Assessment of target miRNA and protein levels, drug sensitivity, and cell migration.

Main Results:

  • The multi-potent miRNA sponge efficiently inhibited four targeted oncogenic miRNAs (miR-21, miR-155, miR-221/222) in cancer cells.
  • A stable cell line demonstrated sustained reduction of target miRNAs and increased target protein levels.
  • The miRNA sponge sensitized cancer cells to chemotherapy drugs and reduced their migratory potential.

Conclusions:

  • The multi-potent miRNA sponge is an effective tool for simultaneously inhibiting multiple oncogenic miRNAs.
  • This approach offers a novel strategy for studying the functional impact of combined miRNA inhibition.
  • The developed miRNA sponge shows therapeutic potential for cancer treatment by modulating oncogenic pathways.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

12.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K